MB
RLAY icon

MPM BioImpact’s Relay Therapeutics RLAY Stock Holding History

MPM BioImpact’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.5M Buy
2,359,586
+127,135
+6% +$1.14M 1.81% 24
2025
Q4 		$18.9M Sell
2,232,451
-50,229
-2% -$358K 2.16% 21
2025
Q3 		$11.9M Hold
2,282,680
– – 1.95% 24
2025
Q2 		$7.9M Sell
2,282,680
-13,244
-0.6% -$39.4K 1.37% 34
2025
Q1 		$6.02M Buy
2,295,924
+27,099
+1% +$106K 1.03% 36
2024
Q4 		$9.35M Buy
2,268,825
+235,784
+12% +$1.28M 1.33% 33
2024
Q3 		$14.4M Buy
2,033,041
+758,582
+60% +$5.67M 2.16% 17
2024
Q2 		$8.31M Buy
1,274,459
+442,442
+53% +$3.02M 1.29% 31
2024
Q1 		$6.91M Hold
832,017
– – 1.11% 34
2023
Q4 		$9.16M Sell
832,017
-520,116
-38% -$4.39M 2.14% 21
2023
Q3 		$11.4M Sell
1,352,133
-2,235
-0.2% -$24K 3.04% 13
2023
Q2 		$17M Buy
1,354,368
+128,734
+11% +$1.6M 3.43% 10
2023
Q1 		$20.2M Buy
+1,225,634
New +$22M 5.24% 7

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return